16.04.2018 | Letter to the Editor
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to l-asparaginase
Erschienen in: Annals of Hematology | Ausgabe 9/2018
Einloggen, um Zugang zu erhalten